PEUTZ-JEGHERS SYNDROME
DEFINITION:
A disorder involving the intestines characterized by masses of
hamartomatous polyps, mucocutaneous pigmentation, and
extraintestinal manifestations (tumors).
EPIDEMIOLOGY:
- incidence: rare
- age of onset:
- risk factors:
- familial - autosomal dominant
- chrom.#: 19p13.3
- gene: serine threonine kinase-11 (STK11)
PATHOGENESIS:
- there are two disorders associated with hamartomatous polyps
in childhood:
2. Hamartomatous Polyps
- this particular type of polyp represents a developmental
malformation affecting the glands and lamina propria of the
intestinal wall
- these lesions consist of essentially normal mucosal
components arranged abnormally, hence the term hamartomatous
- histologically, consist of a branching framework of
connective tissue and smooth muscle lined by normal intestinal
epithelium and containing numerous goblet cells
3. Malignancy Potential
- patients may have a genetic predisposition to develop
neoplasms
- malignant transformation of hamartomatous polyps into
carcinoma may occur in 2-3% of patients; may metastasize
- sarcomatous transformation of hamartomatous polyps into
leiomyosarcoma may also occur
- it has been suggested that the gastrointestinal carcinomas
do not arise from the harmartomatous polyps but from coexistent
adenomas
4. Genetic Defect
- genetic mutation of the STK11 gene -> disruption of the
kinase domain -> diminished STK11 activity -> clinical
manifestations
- several mutations have been identified in the STK11 gene in
patients with Peutz-Jeghers Syndrome including a deletion of
exons 4 and 5, an inversion of exons 6 and 7, a nonsense
mutation, and an acceptor splice-site mutation (Jenne, D.E. et
al., Nature Genetics 18(1):38 (1998))
CLINICAL FEATURES:
- abdominal pain - colicky, recurrent, secondary to
intussusception
3. Complications
- small bowel obstruction
- malignancy potential: carcinoma of stomach, small
intestine, colon
2. Mucocutaneous Pigmentation
- appear in infancy or early childhood and tend to disappear
during puberty
- may be only clinical manifestation of syndrome
- sites of involvement
- common - lips, buccal mucosa, nasolabial folds
- uncommon - hands, feet, rectal, perianal, genital
3. Extraintestinal Tumors
1. Benign
- nasal, tonsils, thyroid, bronchial, breast, pancreas,
adrenal, urinary tract (bladder), uterus, ovaries
2. Malignant
- tongue, bilateral breast carcinoma, biliary tract,
pancreas
- gonadal neoplasia
- sex cord tumors with annular tubules of the ovary or
testis
4. Others
- clubbing
- occasional exostoses (overgrowth of bone -> benign tumor)
INVESTIGATIONS:
1. Colonoscopy/Endoscopy
2. Imaging Studies
- barium enema with air contrast
- upper GI series
3. Biopsy
- hamartomatous polyps 0.1 -> 3 cm in diameter
- distribution of polyps:
- stomach (25%), colon (30%), small bowel (100%)
- occur singly or muliply
MANAGEMENT:
1. Supportive
- regular follow-up with neoplastic screening
- watch for iron-deficiency anemia
2. Surgery
- limited resections with polypectomy if indicated (i.e., for
intussusception, bowel ischemia)
- for extraintestinal tumors
|